Login / Signup

Biopolymer-based tumor microenvironment-responsive nanomedicine for targeted cancer therapy.

Abhishek JhaManish KumarKanchan BhartiManjit ManjitBrahmeshwar Mishra
Published in: Nanomedicine (London, England) (2024)
Nanomedicine has opened up new avenues for cancer treatment by enhancing drug solubility, permeability and targeted delivery to cancer cells. Despite its numerous advantages over conventional therapies, nanomedicine may exhibit off-target drug distribution, harming nontarget regions. The increased permeation and retention effect of nanomedicine in tumor sites also has its limitations, as abnormal tumor vasculature, dense stroma structure and altered tumor microenvironment (TME) may result in limited intratumor distribution and therapeutic failure. However, TME-responsive nanomedicine has exhibited immense potential for efficient, safe and precise delivery of therapeutics utilizing stimuli specific to the TME. This review discusses the mechanistic aspects of various TME-responsive biopolymers and their application in developing various types of TME-responsive nanomedicine.
Keyphrases
  • cancer therapy
  • drug delivery
  • small molecule
  • emergency department
  • endothelial cells
  • electronic health record